These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17065571

  • 21. Minor neurological dysfunction, cognitive development, and somatic development at the age of 3 to 7 years after dexamethasone treatment in very-low birth-weight infants.
    Kutschera J, Tomaselli J, Maurer U, Mueller W, Urlesberger B.
    Early Hum Dev; 2005 Mar; 81(3):281-7. PubMed ID: 15814210
    [Abstract] [Full Text] [Related]

  • 22. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM, Benders MJ, Roescher AM, van Bel F, de Vries LS, Bos AF.
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [Abstract] [Full Text] [Related]

  • 23. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens.
    Kari MA, Akino T, Hallman M.
    Pediatr Res; 1995 Nov; 38(5):676-84. PubMed ID: 8552433
    [Abstract] [Full Text] [Related]

  • 24. Functional outcome at school age of preterm-born children treated with high-dose dexamethasone.
    Hitzert MM, Van Braeckel KN, de Bok M, Maathuis CG, Roze E, Bos AF.
    Early Hum Dev; 2014 May; 90(5):253-8. PubMed ID: 24602475
    [Abstract] [Full Text] [Related]

  • 25. Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.
    Hirvikoski T, Lindholm T, Lajic S, Nordenström A.
    Acta Paediatr; 2011 Sep; 100(9):e112-9. PubMed ID: 21388450
    [Abstract] [Full Text] [Related]

  • 26. Role of the NMDA receptor in cognitive deficits, anxiety and depressive-like behavior in juvenile and adult mice after neonatal dexamethasone exposure.
    Li SX, Fujita Y, Zhang JC, Ren Q, Ishima T, Wu J, Hashimoto K.
    Neurobiol Dis; 2014 Feb; 62():124-34. PubMed ID: 24051277
    [Abstract] [Full Text] [Related]

  • 27. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up.
    Rademaker KJ, de Vries LS, Uiterwaal CS, Groenendaal F, Grobbee DE, van Bel F.
    Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F58-63. PubMed ID: 17848504
    [Abstract] [Full Text] [Related]

  • 28. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA, Harrison M, Clark RH.
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [Abstract] [Full Text] [Related]

  • 29. Effects of neonatal dexamethasone treatment on the cardiovascular stress response of children at school age.
    Karemaker R, Karemaker JM, Kavelaars A, Tersteeg-Kamperman M, Baerts W, Veen S, Samsom JF, van Bel F, Heijnen CJ.
    Pediatrics; 2008 Nov; 122(5):978-87. PubMed ID: 18977976
    [Abstract] [Full Text] [Related]

  • 30. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
    Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, Ikonen RS.
    Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070
    [Abstract] [Full Text] [Related]

  • 31. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
    Durand M, Sardesai S, McEvoy C.
    Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
    [Abstract] [Full Text] [Related]

  • 32. Dexamethasone but not the equivalent doses of hydrocortisone induces neurotoxicity in neonatal rat brain.
    Feng Y, Kumar P, Wang J, Bhatt AJ.
    Pediatr Res; 2015 May; 77(5):618-24. PubMed ID: 25665056
    [Abstract] [Full Text] [Related]

  • 33. Non-neurological, steroid-related adverse events in very low birth weight infants: a prospective audit.
    Röhr SB, Sauer H, Gottschling S, Abdul-Khaliq H, Gortner L, Nunold H, Gräber S, Meyer S.
    Swiss Med Wkly; 2014 May; 144():w13954. PubMed ID: 24706463
    [Abstract] [Full Text] [Related]

  • 34. Early life factors predict abnormal growth and bone accretion at prepuberty in former premature infants with/without neonatal dexamethasone exposure.
    Wang D, Vandermeulen J, Atkinson SA.
    Pediatr Res; 2007 Jan; 61(1):111-6. PubMed ID: 17211151
    [Abstract] [Full Text] [Related]

  • 35. Dose-related inhibition of proinflammatory cytokine release from neutrophils of the newborn by dexamethasone, betamethasone, and hydrocortisone.
    Irakam A, Miskolci V, Vancurova I, Davidson D.
    Biol Neonate; 2002 Aug; 82(2):89-95. PubMed ID: 12169830
    [Abstract] [Full Text] [Related]

  • 36. Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy.
    Kari MA, Raivio KO, Stenman UH, Voutilainen R.
    Pediatr Res; 1996 Aug; 40(2):319-24. PubMed ID: 8827784
    [Abstract] [Full Text] [Related]

  • 37. Motor ability and weight status are determinants of out-of-school activity participation for children with developmental coordination disorder.
    Fong SS, Lee VY, Chan NN, Chan RS, Chak WK, Pang MY.
    Res Dev Disabil; 2011 Aug; 32(6):2614-23. PubMed ID: 21767931
    [Abstract] [Full Text] [Related]

  • 38. Neuropsychological and behavioral effects of postnatal dexamethasone in extremely low birth weight preterm children at early school age.
    Crotty KC, Ahronovich MD, Baron IS, Baker R, Erickson K, Litman FR.
    J Perinatol; 2012 Feb; 32(2):139-46. PubMed ID: 21546939
    [Abstract] [Full Text] [Related]

  • 39. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
    Feldman DM, Carbone J, Belden L, Borgida AF, Herson V.
    Am J Obstet Gynecol; 2007 Sep; 197(3):284.e1-4. PubMed ID: 17826422
    [Abstract] [Full Text] [Related]

  • 40. Neonatal dexamethasone treatment affects social behaviour of rats in later life.
    Kamphuis PJ, Croiset G, Bakker JM, Van Bel F, Van Ree JM, Wiegant VM.
    Neuropharmacology; 2004 Sep; 47(3):461-74. PubMed ID: 15275835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.